The high figure of White may be accounted for by the fact that he quotes reports from several specialised units or hospitals where some degree of selection must have been inevitable. The figures from Northern Ireland on the other hand include all births in the country over that period, both hospital and domiciliary. In addition, the radiotherapy service covers the whole country and approximately 90 per cent of all new breast cancers occurring are registered at the Radiotherapy Centre. For geographical and other reasons there is very little population movement or loss of clinical material.
The table also indicates that in the eleven year period just over 3,000 new breast cancer cases were registered at the Radiotherapy Centre. In that time 59 patients were seen in which pregnancy complicated the condition, i.e., 45 cases where breast cancer appeared in pregnancy or lactation and 14 cases where pregnancy followed previously treated breast cancer. The figure of 1.9 per cent is almost identical to the 2 per cent figure quoted by White (1958) from several New York and Seattle hospitals but lower than the 2.9 per cent given earlier by the same author in a collected series of 43,931 cases (1955) . These figures refer to breast cancer patients of all ages but when the child bearing age is considered, then pregnancy complicating breast cancer is not an uncommon occurrence. Most of the patients with this combination must be found in the 30 to 40 age group and this was the case in this present series (Tables 2 and 3) . This indicates that 14 patients out of 45 where breast cancer appeared during pregnancy or lactation, and 8 patients out of 14 where pregnancy followed previously treated breast cancer, were nulliparous or had one child. This quite clearly is a factor one would have to take into consideration on the question of therapeutic abortion or the advisability of future pregnancies.
Of the 59 cases registered at the Centre, 45 were patients where the breast cancer was seen either with pregnancy or lactation and 14 were patients where pregnancy occurred following previous breast cancer treatment. In 37 of these patients it was possible to produce a five year survival comparison and this is illustrated in Table V. Byrd et al (1962) , 55.2 per cent. In many reports, however, it is difficult to determine overall 5 year survival rates because of the many qualifications such as operability, presence or absence of metastases, etc. The figures are certainly not very dissimilar to non-pregnant breast cancer patients when comparable age groups and stages are matched.
Practically all previous reports have indicated that the prognosis is influenced to a very great degree by the stage of pregnancy in which treatment was initiated. Our experience is illustrated in Table VI . This certainly suggests a higher survival rate in the first trimester and is very much in keeping with the experience of others. White (1958) found 16.3 per cent survivals in the first trimester, 8 per cent in the second and 9.7 per cent in the third. Peters (1962) reported 25 per cent for the first trimester, none for the second and 11 per cent for the third with a figure of 50 per cent for those treated after the termination of pregnancy.
Prognosis, too, could obviously be expected to bear a relationship to clinical staging and Table VII clearly confirms that the earlier the condition is detected the better the prognosis. There were no survivors in the six cases found in Stage 3 and Stage 4 whilst in the remaining 21 patients allocated to Stage 1 and Stage 2 there were 10 five year survivors, i.e., 47.5 per cent. The importance of determining involvement of homolateral axillary nodes will be referred to later.
PATHOLOGY
The pathology reports were not particularly helpful in this series, possibly because of the fact that almost half of the patients were treated by simple mastectomy, but it is interesting to note that there were 6 five year survivors out of 14 where the tumour was described as 'anaplastic carcinoma', i.e., 43 per cent. MANAGEMENT The actual treatment methods or techniques carried out in this particular series are illustrated in Table VIII . The table, if nothing else, demonstrates the involved tortured thinking brought to bear on what can often be a very difficult problem. Three patients were treated either by radiotherapy or some palliative procedure whilst in the remaining 18, treatment was by mastectomy, either simple or radical, in association with post-operative x-ray therapy, therapeutic abortion and/or castration. Most other reports indicate that the prognosis is influenced to a very great degree by the involvement of the homo-lateral axillary nodes, but in this particular series 9 patients were treated by simple mastectomy and consequently no information was available on this point. In the 9 patients treated by radical mastectomy positive glands were reported in five and of these one survived five years. In the other 4 patients with negative glands there were two five year survivors. This shows 4 five year survivors, i.e., 40 per cent. Peters reports 32 per cent survivors out of 38, i.e., 72 per cent in a similar group, whilst White in a collected series reports 59 per cent five year survival. The literature certainly suggests that the prognosis in this particular group is good, but it must be kept in mind that this is a very select group in that the very nature of the disease itself eliminates, at an early stage, those patients with an aggressive form of cancer.
COMMENT As more reports appear on the association of breast cancer and pregnancy the previously held pessimistic views are being replaced, to some extent, by a more optimistic approach to the problem. This present review would suggest or confirm that a more hopeful outlook is not entirely unjustified, but, even accepting this, it has to be admitted that the combination often presents difficult, involved and, at times, almost insoluble problems. The treatment of breast cancer, even in ideal circumstances, can often be a depressing subject but, how much more so is it, when the patient is in her early thirties, when she may have small children and when two lives, not one, are perhaps dependent on the advice given or the decisions taken. Anyone who has had to deal with these cases, will readily appreciate the many considerable pressures that come into play so that rational thought and considered approach to the problem are often very difficult.
How then should such patients be handled? Review of the present group of patients and the literature would suggest that there is a great deal to be gained and very little to be lost by not treating the situation as an emergency, necessiating rapid and, perhaps, hasty decisions. A little delay, more observation of both patient and tumour, an attempt at objective assessment, and full discussion with all others possibly involved in treatment and management must be recommended even in the most difficult and poignant presentation. Practically all authors emphasise, too, that in the first instance, the pregnancy should be ignored altogether and the patient assessed for treatment in the same manner as an uncomplicated breast cancer patient. If the criteria are such as to indicate a radical or potentially curable approach then the problem should be dealt with on this basis.
Earlier in referring to Table VI attention was drawn to the fact that, in this series, and in reports from other centres notably those of Peters and White, the results achieved in the treatment of patients in the latter half of pregnancy were much worse than in those patients treated in the first few months. Recognising this, Peters suggests that, whenever possible, radical treatment for cancer detected in the second half of pregnancy should be delayed until the post-partum period at which time there appears to be a much higher survival rate. Obviously, when the initial diagnosis is made in the last few weeks of pregnancy there would be clear advantages in a minimum period of delay until either Caesarean section or induction were considered appropriate for safe delivery, but on the other hand, when diagnosed at an earlier stage it must be difficult not to recommend radical or definitive treatment. It is certainly very hard to understand why results achieved in those cases treated in the latter half of pregnancy should be so poor and also why delay in the treatment of such patients until the post-partum period should, or could, result in any appreciable improvement in results. It may possibly be that in the late stages of pregnancy, surgery on a distended vascular breast is a traumatic insult of such magnitude as to overwhelm the immune and other body defences, and certainly the evidence is such, and the results so poor, as to suggest that serious consideration be given to the policy advocated by Peters.
In this present series it can be seen that almost half the patients treated were submitted to simple mastectomy followed by radical x-ray therapy. TIhis on reflection, was probably not the best approach in many cases, for there are at least two big advantages in radical mastectomy over simpler surgical procedures.
1. Following radical mastectomy there should, in most cases, be no question of radiation therapy, whereas, with simple mastectomy, radiation is considered to play a major role in treatment. Although the x-rays are directed to the upper chest and shoulder, scatter is inevitable and in the Adrian Committee Report of 1960 we note that the gonadal dose received in the treatment of breast cancer has been estimated at 7.79r. It is not unreasonable to suggest that the foetus, in the early stages of pregnancy and when most vulnerable must be exposed to a similar dose, and this, in most circumstances, must be regarded as unacceptable.
2. In the radical mastectomy specimen an opportunity is afforded to determine the involvement or otherwise of the homolateral axillary nodes. White (1955 ), Miller (1962 , Byrd et al (1962) , Holleb and Farrow (1962) and Austin (1960) all refer to this as a most important factor in determining prognosis. This, of course, is true for non-pregnant breast cancer patients, but many reports on this particular association indicate that the prognosis for those patients without metastases is five to ten times better than those with metastases. Possession of such knowledge could, then, be regarded as vitally important when further management is discussed not alone with ones colleagues, but with the patient, the patient's husband or relatives.
The question of the termination of pregnancy inevitably arises in any discussion on the management of these cases and indeed there has been considerable controversy on the benefits of abortion. Many specialists have felt that immdiate termination of pregnancy would improve the survival rate but there is little or no statistical evidence to confirm these views. The information available at present, indeed, would appear to suggest that no clear benefit can be demonstrated from abortion, and this is the view held by White (1955) in reviewing 1,375 cases from 144 published articles. A similar conclusion was reached by Peters (1962) in reporting 70 cases treated at the Ontario Cancer Institute, and a study of recent literature would only appear to confirm this opinion. One accepts that there are many factors to be taken into account in reaching a decision on this particular aspect of management, but equally, in view of the present available evidence, one would hesitate to recommend termination of pregnancy as a routine procedure in the operable breast cancer patient.
Apart from the advisability of therapeutic abortion, radiation or surgical castration will almost certainly come into consideration in the treatment of these patients. In assessing the possible benefits of such a procedure, it must be remembered that oophorectomy, as far as we know, cannot be regarded as a curative measure in the treatment of breast cancer. Review of the literature, too, would suggest that there is no proof indicating that oophorectomy influences the survival rate in breast cancer developing in pregnancy, and clearly there can be little or no indication for recommending castration as a routine measure in early potentially curable cases. Peters, indeed, suggests that in this particular instance the more favourable cases in the younger age group would be deprived of the possible benefits of future pregnancies by such a procedure.
So far reference has only been made to those patients with an early curable breast cancer discovered in pregnancy. If, on the other hand, the patient presents with advanced local disease and/or metastases, then the real problems or difficulties arise If this, indeed, is the position, there can be no one treatment policy to recommend or follow but all the measures mentioned -surgery, radiation, therapeutic abortion, hormone therapy, castration, pituitary ablation, and chemotherapy may be tried singly or in combination. Invariably, the response to treatment recommended is minimal and, in the circumstances, the policy must be one of individualisation with many factors other than clinical ones, playing a more important role in determining or influencing the advice given and the measures taken. Here indeed lies the real tragedy of breast cancer associated with pregnancy, ror very often, in these circumstances, the apparently inevitable end result is the death of both baby and mother. Such an outcome certainly must leave a lasting impression on those associated with treatment and subsequently could very well influence, adversely, individual judgment on the management of even the earliest breast cancer in pregnancy. This, together with the low incidence of the particular association would suggest that centralisation of treatment of such patients, would almost certainly be beneficial. Not least of these benefits would be the fact that sufficient numbers could be compiled to enable proper statistical evaluation of many of the factors associated with treatment. One might best illustrate the infrequency of the association by referring again to the figures here in Northern Ireland which suggest that a general surgeon, on average, sees one such patient every eight to ten years.
Finally, reference must be made to that group of patients where pregnancy follows treatment for cancer of the breast. In this present series, there were 14 such patients and ten were available for evaluation. Four of the 10 were alive and well at five years. Here again numbers are very small, but reference has already been made to the 72 per cent five year survival figure of Peters and the 59 per cent of White in similar, but very much larger, groups. This would appear to be the experience of others, and the overall figures are such as to suggest that patients in this group do even better than breast cancer patients without pregnancy. This, of course, is a select group in that the very nature of the breast cancer eliminates, at an early stage, those patients with an aggressive form of the disease. Whilst this is true, problems will still arise and before offering advice many factors should be considered, i.e., age of patient, size of family, history and extent of the previously treated breast cancer, involvement or otherwise of the homolateral axillary nodes, the histologic grading and previous radiation or chemo-therapy. Many reports would suggest that pregnancy should be delayed for two years following mastectomy and although this is largely an arbitrary determination most would regard it as reasonable. If, however, many of the prognostic factors mentioned are poor then further delay should be advised for, indeed, one must keep in mind the fact that the combination of recurrent and/or metastatic breast cancer and pregnancy is truly a clinical catastrophe (Fig. 1) unlikely to be influenced to any degree by present day therapy. SUMMARY Three thousand breast cancer cases, registered at the Northern Ireland Radiotherapy Centre, were reviewed and pregnancy was found to complicate the condition in 59 patients, i.e., 2 per cent. Where only those patients under the age of 40 were considered 19 per cent had concurrent pregnancy or became pregnant after treatment of their breast cancer. In 45 of the patients the breast cancer appeared in pregnancy or lactation and in the remaining 14 pregnancy followed treatment of a breast cancer.
Management is discussed and the advantages of radical mastectomy over simpler surgical procedures is commented upon with the observation that radiation therapy would appear to have little part to play in the treatment of early cases. As in other series there was a higher survival rate in those cases treated in the early months of pregnancy with therapeutic abortion and castration apparently having little or no bearing on the prognosis. It is suggested that these procedures, if not actually contra-indicated, should certainly not be recommended routinely in the operable or potentially curable patient.
In the cases reviewed it was noted that where breast cancer developed in pregnancy or lactation 37 per cent of the patients survived five years. This is a figure rather similar to other recently published reports and suggests or confirms that the prognosis, where breast cancer is associated with pregnancy, is not very different from similar groups of non-pregnant patients. In the group of patients where pregnancy followed previously treated breast cancer 40 per cent survived five years and the many factors believed to be relevant to the prognosis, or to be considered when advising on subsequent pregnancies are detailed. The review also indicates that one case of breast cancer may be expected for every 7,500 births and it is suggested that because of the infrequency of the condition and the many problems involved in management centralisation of the treatment of such cases might be usefully considered. The importance of objective discussion and assessment of such patients on the same basis as the uncomplicated breast cancer case is stressed. (Some of the points referred to in the discussion are illustrated in six case reports). 
